Home Biotechnology CinnaGen
C

CinnaGen

Profile managed by Bizz Id
Iran 1994

Description

CinnaGen is an Iranian biopharmaceutical group that develops and manufactures biologic medicines —recombinant proteins, monoclonal antibodies and biosimilars— for autoimmunity, oncology, neurology, endocrinology and infertility. It is headquartered in Tehran with a manufacturing site in Karaj; according to its website, its medicines reach more than 70 countries.

Products

32 products
Adalimumab

Brand: CinnoRA (40 mg). 40 mg/0.8 mL autoinjector. Rheumatoid arthritis and other inflammatory diseases.

Finished product (FDF)

Verified on 2026-10-21

Adalimumab: see suppliers →

Aflibercept

Brand: Tyalia (40 mg). Intravitreal injection. Wet AMD, diabetic macular oedema, diabetic retinopathy and other eye conditions.

Finished product (FDF)

Verified on 2026-10-21

Aflibercept: see suppliers →

Amphotericin B, Liposome for Injection

Brand: Alentiva (50 mg). Antifungal. Severe systemic and/or deep mycoses (disseminated candidiasis, aspergillosis, cryptococcosis, chronic mycetoma, mucormycosis) in adults and children from 1 month.

Finished product (FDF)

Verified on 2026-10-21

Amphotericin B: see suppliers →

Buserelin Acetate

Brand: CinnaFact (1 mg). Synthetic peptide GnRH analogue. Endometriosis and infertility treatment.

Finished product (FDF)

Verified on 2026-10-21

Buserelin: see suppliers →

Cetrorelix Acetate

Brand: Lixafert (250 mcg). Prevention of premature ovulation in assisted reproductive techniques.

Finished product (FDF)

Verified on 2026-10-21

Cetrorelix: see suppliers →

Cetuximab

Brand: Araxya (5 mg). Monoclonal antibody. Metastatic large intestine cancer (alone or in combination, including with encorafenib in BRAF-mutant disease) and head and neck cancer.

Finished product (FDF)

Verified on 2026-10-21

Cetuximab: see suppliers →

Daratumumab

Brand: Acravia (100 mg, 400 mg). Human anti-CD38 monoclonal antibody. Newly diagnosed and relapsed/refractory multiple myeloma.

Finished product (FDF)

Verified on 2026-10-21

Daratumumab: see suppliers →

Eculizumab

Brand: Ablyze (10 mg). Humanized IgG monoclonal antibody binding complement C5. PNH, aHUS, generalized myasthenia gravis and NMOSD.

Finished product (FDF)

Verified on 2026-10-21

Eculizumab: see suppliers →

Enoxaparin sodium

Brand: CinnaStim (2000–10000 IU). Syringes. Treatment and prevention of blood clots (peri-operative, immobilisation) and unstable angina.

Finished product (FDF)

Verified on 2026-10-21

Enoxaparin: see suppliers →

Epoetin beta

Brand: Cinnapoietin (erythropoietin β). Recombinant human erythropoietin produced in CHO cells, prefilled syringes. Anaemia of chronic kidney disease, autologous blood pre-donation and prevention of anaemia of prematurity.

Finished product (FDF)

Verified on 2026-10-21

Epoetin: see suppliers →

Evolocumab

Brand: Eldona (140 mg). Monoclonal antibody. Reduction of major adverse cardiovascular events in high-risk adults and hyperlipidaemia.

Finished product (FDF)

Verified on 2026-10-21

Evolocumab: see suppliers →

Filgrastim

Brand: Nowaria (300 mcg/0.5 mL prefilled syringe). Chemotherapy-induced myelosuppression, AML, bone marrow transplantation, acute radiation syndrome and progenitor cell mobilisation.

Finished product (FDF)

Verified on 2026-10-21

Filgrastim: see suppliers →

Follitropin alfa

Brand: Cinnal-f (75, 150, 300, 450, 900 IU). Prefilled pen. Ovarian stimulation, assisted reproductive technology and anovulation (with lutropin alfa).

Finished product (FDF)

Verified on 2026-10-21

Follitropin alfa: see suppliers →

Glatiramer Acetate

Brand: Cinnomer (20, 40 mg). Relapsing forms of multiple sclerosis.

Finished product (FDF)

Verified on 2026-10-21

Glatiramer: see suppliers →

Guselkumab

Brand: Eldixia (100 mg). Human IgG1 monoclonal antibody in prefilled syringe. Moderate to severe plaque psoriasis in adults.

Finished product (FDF)

Verified on 2026-10-21

Guselkumab: see suppliers →

Insulin glargine

Brand: Gylava (100 IU). Diabetes mellitus in adults, adolescents and children aged 2 and above.

Finished product (FDF)

Verified on 2026-10-21

Insulin glargine: see suppliers →

Interferon beta-1a (22/44/132 mcg)

Brand: ReciGen (22, 44, 132 mcg). Prefilled syringe. Relapsing forms of multiple sclerosis.

Finished product (FDF)

Verified on 2026-10-21

Interferon beta-1a: see suppliers →

Interferon beta-1a (30 mcg)

Brand: CinnoVex (30 mcg). Relapsing multiple sclerosis.

Finished product (FDF)

Verified on 2026-10-21

Interferon beta-1a: see suppliers →

Laronidase

Brand: Herozyme (580 mcg). Enzyme replacement. Non-neurological manifestations of mucopolysaccharidosis type I (MPS I).

Finished product (FDF)

Verified on 2026-10-21

Laronidase: see suppliers →

Liraglutide (type 2 diabetes)

Brand: Melitide (6 mg/mL). GLP-1 analogue. Type 2 diabetes in adults and children aged 10+ and cardiovascular risk reduction.

Finished product (FDF)

Verified on 2026-10-21

Liraglutide: see suppliers →

Liraglutide (weight management)

Brand: Maciza (6 mg/mL; 18 mg/3 mL pen). GLP-1 analogue. Weight management in adults with obesity or overweight with comorbidity.

Finished product (FDF)

Verified on 2026-10-21

Liraglutide: see suppliers →

Nivolumab

Brand: Xtramab (40, 100, 240 mg). Fully human IgG4 anti-PD-1 monoclonal antibody. Melanoma, NSCLC and other cancers.

Finished product (FDF)

Verified on 2026-10-21

Nivolumab: see suppliers →

Ocrelizumab

Brand: Xacrel (30 mg). Humanized anti-CD20 monoclonal antibody. Relapsing and primary progressive multiple sclerosis.

Finished product (FDF)

Verified on 2026-10-21

Ocrelizumab: see suppliers →

Omalizumab

Brand: Zerafil (150 mg). Anti-IgE monoclonal antibody. Moderate to severe persistent allergic asthma, chronic spontaneous urticaria and other indications.

Finished product (FDF)

Verified on 2026-10-21

Omalizumab: see suppliers →

Pegfilgrastim (3 mg)

Brand: KidiPeg. 3 mg/0.3 mL prefilled syringe (product list shows "10, 50 mg"). Decreases infection (febrile neutropenia) in non-myeloid malignancies on myelosuppressive therapy.

Finished product (FDF)

Verified on 2026-10-21

Pegfilgrastim: see suppliers →

Pegfilgrastim (6 mg)

Brand: PegaGen (6 mg). Prevention of chemotherapy-induced neutropenia.

Finished product (FDF)

Verified on 2026-10-21

Pegfilgrastim: see suppliers →

Pembrolizumab

Brand: ZakAria (25 mg). Humanized anti-PD-1 monoclonal antibody. Melanoma, Merkel cell carcinoma, lung, head and neck cancer, lymphomas and other cancers.

Finished product (FDF)

Verified on 2026-10-21

Pembrolizumab: see suppliers →

Pertuzumab

Brand: Pectuna (30 mg). Anti-HER2 monoclonal antibody. Early and metastatic breast cancer.

Finished product (FDF)

Verified on 2026-10-21

Pertuzumab: see suppliers →

Recombinant COVID-19 Vaccine

Brand: SpikoGen (25 mcg). Recombinant SARS-CoV-2 Spike protein with Advax-SM adjuvant, produced in cooperation with Vaxine (Australia). Primary vaccination and booster.

Other

Verified on 2026-10-21

Somatropin

Brand: CinnaTropin (4, 10, 20 IU). Recombinant growth hormone in prefilled pen. Growth failure due to GH deficiency, Turner syndrome and other paediatric indications.

Finished product (FDF)

Verified on 2026-10-21

Somatropin: see suppliers →

Teriparatide

Brand: CinnoPar (250 mcg); Zandoriah in the EU. Recombinant human parathyroid hormone analogue, biosimilar to Forsteo. Postmenopausal, male and glucocorticoid-induced osteoporosis at high fracture risk.

Dictamen positivo CHMP

Filing submitted

Finished product (FDF)

Verified on 2026-10-21

Teriparatide: see suppliers →

Tirzepatide

Brand: Spartina (2.5–15 mg). Type 2 diabetes and weight loss and maintenance in adults.

Finished product (FDF)

Verified on 2026-10-21

Tirzepatide: see suppliers →

Contact company

Register for free to see this company’s contact details and get in touch.

Register - Free